Pleno: Clinical And Multi-Omics Diagnostics Company Raises $25 Million (Series B)
By Amit Chowdhry ● Dec 14, 2024
Pleno, a clinical and multi-omics diagnostics company revolutionizing biological target detection, announced the appointment of Dr. Vik Vaz, M.D., as its new chief executive officer and to serve on its Board of Directors, effective immediately.Dr. Vaz will lead Pleno’s next growth phase as the company prepares to scale its commercial operations with the help of its new $25 million Series B funding. The key investors, Deerfield Management, Foresite Capital, and Medical Excellence Capital, remain committed to supporting the next phase of the company’s growth strategy.